Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Dongyu Sun

SM16, an Orally Active TGF- Type I Receptor Inhibitor Prevents Myofibroblast Induction and Vascular Fibrosis in the Rat Carotid Injury Model

Arteriosclerosis, Thrombosis, and Vascular Biology

Cardiovascular Medicine

Cardiology

2008

English

Adopting a Practical Statistical Approach for Evaluating Assay Agreement in Drug Discovery

Journal of Biomolecular Screening

English

Related publications

An Orally Active Chemokine Receptor CCR2 Antagonist Prevents Glomerulosclerosis and Renal Failure in Type 2 Diabetes

Kidney International

Nephrology

2011

English

A Novel Small-Molecule Inhibitor of Transforming Growth Factor Type I Receptor Kinase (SM16) Inhibits Murine Mesothelioma Tumor Growth in Vivo and Prevents Tumor Recurrence After Surgical Resection

Cancer Research

Oncology

2007

English

MEK Inhibition Prevents TGF‑β1‑induced Myofibroblast Transdifferentiation in Human Tenon Fibroblasts

Molecular Medicine Reports

English

Toll-Like Receptor 7-Mediated Type I Interferon Signaling Prevents Cholestasis- And Hepatotoxin-Induced Liver Fibrosis

English

Orally Active Epoxyeicosatrienoic Acid Analog Attenuates Kidney Injury in Hypertensive Dahl Salt-Sensitive Rat

Hypertension

Internal Medicine

2013

English

In the Absence of Type III Receptor, the Transforming Growth Factor (TGF)-β Type II-B Receptor Requires the Type I Receptor to Bind TGF-β2

Journal of Biological Chemistry

English

Development of an ALK2-Biased BMP Type I Receptor Kinase Inhibitor

English

LCZ696 (Sacubitril/Valsartan), an Angiotensin-Receptor Neprilysin Inhibitor, Attenuates Cardiac Hypertrophy, Fibrosis and Vasculopathy in a Rat Model of Chronic Kidney Disease

Journal of Cardiac Failure

Cardiovascular Medicine

Cardiology

2018

English

TACE-Mediated Ectodomain Shedding of the Type I TGF-β Receptor Downregulates TGF-β Signaling

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Dongyu Sun

SM16, an Orally Active TGF- Type I Receptor Inhibitor Prevents Myofibroblast Induction and Vascular Fibrosis in the Rat Carotid Injury Model

Adopting a Practical Statistical Approach for Evaluating Assay Agreement in Drug Discovery

Related publications

An Orally Active Chemokine Receptor CCR2 Antagonist Prevents Glomerulosclerosis and Renal Failure in Type 2 Diabetes

A Novel Small-Molecule Inhibitor of Transforming Growth Factor Type I Receptor Kinase (SM16) Inhibits Murine Mesothelioma Tumor Growth in Vivo and Prevents Tumor Recurrence After Surgical Resection

MEK Inhibition Prevents TGF‑β1‑induced Myofibroblast Transdifferentiation in Human Tenon Fibroblasts

Toll-Like Receptor 7-Mediated Type I Interferon Signaling Prevents Cholestasis- And Hepatotoxin-Induced Liver Fibrosis

Orally Active Epoxyeicosatrienoic Acid Analog Attenuates Kidney Injury in Hypertensive Dahl Salt-Sensitive Rat

In the Absence of Type III Receptor, the Transforming Growth Factor (TGF)-β Type II-B Receptor Requires the Type I Receptor to Bind TGF-β2

Development of an ALK2-Biased BMP Type I Receptor Kinase Inhibitor

LCZ696 (Sacubitril/Valsartan), an Angiotensin-Receptor Neprilysin Inhibitor, Attenuates Cardiac Hypertrophy, Fibrosis and Vasculopathy in a Rat Model of Chronic Kidney Disease

TACE-Mediated Ectodomain Shedding of the Type I TGF-β Receptor Downregulates TGF-β Signaling